Implications of dietary omega-3 fatty acid supplementationon oxidative damage and inflammatory response in type 2 diabetic depressive patients

Background: Diabetes Mellitus (DM) is a major non-communicable health problem that have effects on glycemic status. Oral omega-3 fatty acid supplementation may improve glycemic status in diabetic patient. Objective: To observe the effect of supplementation of omega-3 fatty acid on fasting serum glucose (FSG) and glycosylated hemoglobin (HbA1c) levels in type 2 DM. Methods: This prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients(type-2 DM) of both sexes were selected with age 40 to 50 years. Among them, 27 type 2 diabetic patient with supplementation of omega 3 fatty acid (2g/day) for 12 weeks was considered as study group. Another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid was considered as control group. The study subjects were selected from Outpatient Department of Endocrinology, Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city. FSG was estimated by enzymatic colorimetric method and HbA1c was estimated by turbidimetric inhibition immunoassay method. The study parameters were measured at base line and after 12 weeks of study period in both groups. For statistical analysis, Student’s paired ‘t’ test and Student’s unpaired ‘t’ test were performed as applicable using SPSS for windows version 16.0. Results: In this study serum FSG and HbA1c levels were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to that of their baseline value. Again, after 12 weeks, FSG and HbA1c levels significantly decreased (p<.001) in omega-3 fatty acid supplemented diabetic patients compared to control group. In control group, there was no significant change in FSG and HbA1c levels between baseline and after 3 months of follow-up. Conclusion: From the results of the study, it can be concluded that omega-3 fatty acid may improve serum FSG and HbA1c levels in type 2 diabetic patient and may be helpful to minimize the complications of type-2 DM. J Bangladesh Soc Physiol. 2019, June; 14(1): 33-37

Download Full-text

The effect of fish oil capsule on serum total cholesterol and triglycride levels in type-2 diabetic patient

Journal of Bangladesh Society of Physiologist ◽

10.3329/jbsp.v13i2.39481 ◽

2018 ◽

Vol 13 (2) ◽

pp. 73-77

Author(s):

Tamanna Binte Habib ◽

Qazi Shamima Akhter

Keyword(s):

Fatty Acid ◽

Diabetic Patient ◽

Control Group ◽

Diabetic Patients ◽

Omega 3 ◽

Type 2 Diabetic Patients ◽

Omega 3 Fatty Acid ◽

Type 2 Dm ◽

Type 2 Diabetic

Background: Diabetes Mellitus (DM) is one of the common metabolic disorders that have effects on lipid metabolism. Fish oil supplementation may improve lipid abnormalities in diabetic patient.Objective: To observe the effect of supplementation of omega-3 fatty acid on total cholesterol (TC) and triglyceride(TG) level in type 2 DM. Methods: A prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients of both sexes were selected with age 40 to 50 years. Among them, 27 type 2 diabetic patient with supplementation of omega 3 fatty acid (2g/ day) for 12 weeks was considered as study group. Another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid was considered as control group. The study subjects were selected from Outpatient Department of Endocrinology, Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city.Serum TC and TG were estimated by enzymatic endpoint method in autoanalyzer. The study parameters were measured at base line and after 12 weeks of study period in both groups. For statistical analysis, Paired Student’s‘t’ test and Unpaired Student’s ‘t’ test were performed as applicable using SPSS for windows version 16.0. Results: In this study serumTC and TG levels were significantly lower (p<.001) in diabetic patients after supplementation with omega- 3 fatty acid in comparison to that of their baseline value.Again, after 12 weeks, serum TC and TG levels were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to control group. In control group, serum TC and TG levels were almost similar both at baseline and after 3 months of follow-up. Conclusion: After analyzing the results of the study, it can be concluded that omega-3 fatty acid may improve serum TC and TG levels in type 2 diabetic patient and may be helpful to minimize the complications of type-2 DM. J Bangladesh Soc Physiol. 2018, December; 13(2): 73-77

Download Full-text

The influence of interleukin-6 gene polymorphism on omega-3 fatty acid effect in type 2 diabetic patients

Diabetes & Metabolism ◽

10.1016/j.diabet.2016.07.021 ◽

2016 ◽

Vol 42 (4) ◽

pp. 300

Author(s):

Y. Karachentsev ◽

M. Gorshunska ◽

N. Krasova ◽

E. Jansen ◽

T. Tyzhnenko ◽

...

Keyword(s):

Fatty Acid ◽

Gene Polymorphism ◽

Interleukin 6 ◽

Diabetic Patients ◽

Omega 3 ◽

Type 2 Diabetic Patients ◽

Omega 3 Fatty Acid ◽

Acid Effect ◽

Type 2 Diabetic

Download Full-text

Effects of ɷ - 3 Fatty Acids on Liver Function Tests in Patients with Diabetes Mellitus

Medicine Today ◽

10.3329/medtoday.v32i2.48820 ◽

2020 ◽

Vol 32 (2) ◽

pp. 91-94

Author(s):

Tamanna Binte Habib ◽

Qazi Shamima Akhter ◽

Hasan Imam ◽

Nahid Yeasmin

Keyword(s):

Fatty Acid ◽

Total Protein ◽

Liver Function Tests ◽

Control Group ◽

Diabetic Patients ◽

Omega 3 ◽

Type 2 Diabetic Patients ◽

Omega 3 Fatty Acid ◽

Type 2 Diabetic

Introduction: Patients with type-2 Diabetes are augmented the risk of non alchoholic fatty liver disease that rises liver enzymes and total protein.To observe the favourable effects of fish oil capsule on liver function tests in patients with type 2 DM. Materials and Methods: A prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients of both sexes were scrutinized with age ranging from 40 to 50 years. Among them, 27 type 2 diabetic patients those who taken oral fish oil gel (2g/day) for 12 weeks were preferred as study group. Another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid were nominated as control group for comparison. The study subjects were selected from Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city on the basis of criteria. The research work was administrated with ethical clearance from concerned authority. Results: In this study ALP, LDH, total protein were reduced in diabetic patients after supplementation with omega-3 fatty acid in comparison to that of their baseline value. Again, after 12 weeks, ALP (Alkaline Phosphatase) LDH (Lctate dehydrogenase) and total protein were decreased in diabetic patients after supplementation with omega-3 fatty acid in comparison to control group. Conclusion: After analyzing the results of the study, it can be concluded that omega-3 fatty acid can reduce ALP, LDH and total protein levels in diabetic patients may be helpful to minimize the risk of fatty liver in type-2 diabetes mellitus. Medicine Today 2020 Vol.32(2): 91-94

Download Full-text

The potential benefit of omega-3 fatty acid capsule on Mean platelet volume and Platelet count in type-2 Diabetes Mellitu

Bangladesh Critical Care Journal ◽

10.3329/bccj.v8i1.47707 ◽

2020 ◽

Vol 8 (1) ◽

pp. 37-40

Author(s):

Tamanna Binte Habib ◽

Qazi Shamima Akhter ◽

Hasan Imam ◽

Nahid Yeasmin ◽

Sharmin Nahar ◽

...

Keyword(s):

Platelet Count ◽

Fatty Acid ◽

Control Group ◽

Diabetic Patients ◽

Omega 3 ◽

Glycemic Status ◽

Type 2 Diabetic Patients ◽

Omega 3 Fatty Acid ◽

Type 2 Diabetic

Background: Diabetes Mellitus (DM) is a major non-communicable health problem that has effects on glycemic status. Hyperglycemia that is an inherent finding of diabetes causes platelet dysfunction. Oral omega-3 fatty acid supplementation may improve glycemic status in diabetic patient and reduce micro and macrovascular complications. Objective: To observe the effect of supplementation of omega-3 fatty acid on Mean Platelet Volume (MPV) and Platelet count in type 2 DM. Methods: A prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients of both sexes were selected within age 40 to 50 years. Among them, 27 type 2 diabetic patients with supplementation of omega 3 fatty acid (2g/day) for 12 weeks were considered as study group and another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid were considered as control group. The study subjects were selected from Outpatient Department of Endocrinology, Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city. MPV and platelet count were measured by hematology analyzer. The study parameters were measured at base line and after 12 weeks of study period in both groups. Results: In this study MPV and platelet count levels were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to that of their baseline value. Again, after 12 weeks, MPV and platelet count were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to control group. In control group, MPV and Platelet count were almost similar both at baseline and after 3 months of follow-up. Conclusion: After analyzing the results of the study it can be concluded that omega-3 fatty acid may improve MPV and Platelet count levels in type 2 diabetic patients and may be helpful to minimize the complications of type-2 DM. Bangladesh Crit Care J March 2020; 8(1): 37-40

Download Full-text